Sotera Health Co 8-K

What Happened
Sotera Health Company announced the final results of its 2026 annual meeting of stockholders held May 21, 2026. Stockholders elected all four Class III director nominees to three-year terms (until the 2029 annual meeting), approved on an advisory basis the compensation of the company’s named executive officers, and ratified Ernst & Young LLP as the company’s independent registered public accounting firm for fiscal 2026.

• Election vote totals:
  • Sean L. Cunningham — For: 226,297,734; Withheld: 38,018,512; Broker non-votes: 3,273,595
  • Richard G. Kyle — For: 260,365,658; Withheld: 3,950,588; Broker non-votes: 3,273,595
  • Vincent K. Petrella — For: 251,933,894; Withheld: 12,382,352; Broker non-votes: 3,273,595
  • Christopher A. Simon — For: 253,840,543; Withheld: 10,475,703; Broker non-votes: 3,273,595
• Advisory approval of named executive officer compensation (say-on-pay): For 257,678,396; Against 6,586,053; Abstain 51,797; Broker non-votes: 3,273,595.
• Ratification of independent auditor (Ernst & Young LLP): For 267,310,915; Against 223,069; Abstain 55,857.

Key Details

• Annual meeting date: May 21, 2026.
• Directors elected to serve three-year terms through the 2029 annual meeting.
• Say-on-pay passed with ~97.5% of votes cast in favor among voting shares (excluding broker non-votes).
• Auditor ratification passed overwhelmingly (267.3M votes for).

Why It Matters
These results confirm board continuity and management support: all director nominees were elected and investors endorsed executive compensation in an advisory vote, which signals limited shareholder opposition at this meeting. Ratifying Ernst & Young provides audit continuity for fiscal 2026. For retail investors, these are governance outcomes that affect oversight and accountability but do not by themselves change operations or financial results.